# Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer

> **NCT03297489** · EARLY_PHASE1 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 19 (actual)

## Conditions studied

- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma
- Stage I Ovarian Cancer
- Stage IA Ovarian Cancer
- Stage IB Ovarian Cancer
- Stage IC Ovarian Cancer
- Stage II Ovarian Cancer
- Stage IIA Ovarian Cancer
- Stage IIB Ovarian Cancer
- Stage IIC Ovarian Cancer
- Stage III Ovarian Cancer
- Stage IIIA Ovarian Cancer
- Stage IIIB Ovarian Cancer
- Stage IIIC Ovarian Cancer
- Stage IV Ovarian Cancer

## Interventions

- **PROCEDURE:** Diagnostic Microscopy
- **DRUG:** Fluorescein Sodium Injection
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT03297489
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-06
- **Primary completion:** 2021-02-15
- **Final completion:** 2021-02-15
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03297489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03297489, "Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03297489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*